Medical Device and Diagnostic Industry (MD+DI)

Edwards Unveils Strong TAVR Results at NY Valves 2026

Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.

Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's ...
News-Medical.Net

Landmark study confirms long-term durability of Ross procedure for aortic valve replacement

The Ross procedure, a highly specialized option for aortic valve replacement, is associated with significant long-term ...

New procedure associated with excellent outcomes, durability, efficacy in wide range of adults with aortic valve disease

The Ross Procedure, a highly specialized option for aortic valve replacement, is associated with significant long-term ...